prednisolone
FDA Approved, EMA Approved
Description
Prednisolone is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties. It is widely used as first-line therapy in autoimmune pancreatitis and various vasculitides. The drug suppresses immune responses and reduces inflammation through multiple mechanisms including inhibition of inflammatory mediators.
Indications & Therapeutic Use
autoimmune pancreatitis, medium-vessel vasculitis, inflammatory conditions
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
prednisolone
| Generic Name | prednisolone |
| Brands | 1 brand available |
| Active Ingredient | prednisolone |
| Drug Class | autoimmune pancreatitis |
| Manufacturer | Multiple manufacturers |
| Dosage Forms | Oral tablets 5mg, 10mg, 20mg; oral solution 15mg/5mL |
| Medical Code | H02AB06 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 2 days |
| Reg. Status | FDA Approved, EMA Approved |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes